TCL1A
| T-cell leukemia/lymphoma 1A | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 PDB rendering based on 1jsg. | |||||||||||||
| |||||||||||||
| Identifiers | |||||||||||||
| Symbols | TCL1A ; TCL1 | ||||||||||||
| External IDs | OMIM: 186960 MGI: 1097166 HomoloGene: 7565 GeneCards: TCL1A Gene | ||||||||||||
| |||||||||||||
| RNA expression pattern | |||||||||||||
 | |||||||||||||
 | |||||||||||||
| More reference expression data | |||||||||||||
| Orthologs | |||||||||||||
| Species | Human | Mouse | |||||||||||
| Entrez | 8115 | 21432 | |||||||||||
| Ensembl | ENSG00000100721 | ENSMUSG00000041359 | |||||||||||
| UniProt | P56279 | P56280 | |||||||||||
| RefSeq (mRNA) | NM_001098725 | NM_001289468 | |||||||||||
| RefSeq (protein) | NP_001092195 | NP_001276397 | |||||||||||
| Location (UCSC) | Chr 14: 96.18 – 96.18 Mb | Chr 12: 105.22 – 105.22 Mb | |||||||||||
| PubMed search | |||||||||||||
T-cell leukemia/lymphoma protein 1A is a protein that in humans is encoded by the TCL1A gene.[1][2][3]
Interactions
TCL1A has been shown to interact with AKT1[4][5][6] and AKT2.[4][5]
References
- ↑ Russo G, Isobe M, Gatti R, Finan J, Batuman O, Huebner K et al. (February 1989). "Molecular analysis of a t(14;14) translocation in leukemic T-cells of an ataxia telangiectasia patient". Proc Natl Acad Sci U S A 86 (2): 602–6. doi:10.1073/pnas.86.2.602. PMC 286520. PMID 2783489.
- ↑ Virgilio L, Narducci MG, Isobe M, Billips LG, Cooper MD, Croce CM et al. (February 1995). "Identification of the TCL1 gene involved in T-cell malignancies". Proc Natl Acad Sci U S A 91 (26): 12530–4. doi:10.1073/pnas.91.26.12530. PMC 45472. PMID 7809072.
- ↑ "Entrez Gene: TCL1A T-cell leukemia/lymphoma 1A".
- ↑ 4.0 4.1 Laine J, Künstle G, Obata T, Noguchi M (February 2002). "Differential regulation of Akt kinase isoforms by the members of the TCL1 oncogene family". J. Biol. Chem. 277 (5): 3743–51. doi:10.1074/jbc.M107069200. PMID 11707444. Vancouver style error (help)
- ↑ 5.0 5.1 Laine J, Künstle G, Obata T, Sha M, Noguchi M (August 2000). "The protooncogene TCL1 is an Akt kinase coactivator". Mol. Cell 6 (2): 395–407. doi:10.1016/S1097-2765(00)00039-3. PMID 10983986. Vancouver style error (help)
- ↑ French SW, Shen RR, Koh PJ, Malone CS, Mallick P, Teitell MA (May 2002). "A modeled hydrophobic domain on the TCL1 oncoprotein mediates association with AKT at the cytoplasmic membrane". Biochemistry 41 (20): 6376–82. doi:10.1021/bi016068o. PMID 12009899.
Further reading
- Pekarsky Y, Hallas C, Croce CM (2001). "The role of TCL1 in human T-cell leukemia". Oncogene 20 (40): 5638–43. doi:10.1038/sj.onc.1204596. PMID 11607815.
- Pekarsky Y, Zanesi N, Aqeilan R, Croce CM (2004). "Tcl1 as a model for lymphomagenesis". Hematol. Oncol. Clin. North Am. 18 (4): 863–79, ix. doi:10.1016/j.hoc.2004.04.007. PMID 15325703.
- Noguchi M, Ropars V, Roumestand C, Suizu F (2007). "Proto-oncogene TCL1: more than just a coactivator for Akt". FASEB J. 21 (10): 2273–84. doi:10.1096/fj.06-7684com. PMID 17360849.
- Fu TB, Virgilio L, Narducci MG, Facchiano A, Russo G, Croce CM (1995). "Characterization and localization of the TCL-1 oncogene product". Cancer Res. 54 (24): 6297–301. PMID 7987816.
- Hoh F, Yang YS, Guignard L, Padilla A, Stern MH, Lhoste JM et al. (1998). "Crystal structure of p14TCL1, an oncogene product involved in T-cell prolymphocytic leukemia, reveals a novel beta-barrel topology". Structure 6 (2): 147–55. doi:10.1016/S0969-2126(98)00017-3. PMID 9519406.
- Takizawa J, Suzuki R, Kuroda H, Utsunomiya A, Kagami Y, Joh T et al. (1998). "Expression of the TCL1 gene at 14q32 in B-cell malignancies but not in adult T-cell leukemia". Jpn. J. Cancer Res. 89 (7): 712–8. doi:10.1111/j.1349-7006.1998.tb03275.x. PMID 9738977.
- Pekarsky Y, Hallas C, Isobe M, Russo G, Croce CM (1999). "Abnormalities at 14q32.1 in T cell malignancies involve two oncogenes". Proc. Natl. Acad. Sci. U.S.A. 96 (6): 2949–51. doi:10.1073/pnas.96.6.2949. PMC 15875. PMID 10077617.
- Laine J, Künstle G, Obata T, Sha M, Noguchi M (2000). "The protooncogene TCL1 is an Akt kinase coactivator". Mol. Cell 6 (2): 395–407. doi:10.1016/S1097-2765(00)00039-3. PMID 10983986. Vancouver style error (help)
- Laine J, Künstle G, Obata T, Noguchi M (2002). "Differential regulation of Akt kinase isoforms by the members of the TCL1 oncogene family". J. Biol. Chem. 277 (5): 3743–51. doi:10.1074/jbc.M107069200. PMID 11707444. Vancouver style error (help)
- French SW, Shen RR, Koh PJ, Malone CS, Mallick P, Teitell MA (2002). "A modeled hydrophobic domain on the TCL1 oncoprotein mediates association with AKT at the cytoplasmic membrane". Biochemistry 41 (20): 6376–82. doi:10.1021/bi016068o. PMID 12009899.
- Fears S, Chakrabarti SR, Nucifora G, Rowley JD (2002). "Differential expression of TCL1 during pre-B-cell acute lymphoblastic leukemia progression". Cancer Genet. Cytogenet. 135 (2): 110–9. doi:10.1016/S0165-4608(01)00655-0. PMID 12127395.
- Hoyer KK, French SW, Turner DE, Nguyen MT, Renard M, Malone CS et al. (2002). "Dysregulated TCL1 promotes multiple classes of mature B cell lymphoma". Proc. Natl. Acad. Sci. U.S.A. 99 (22): 14392–7. doi:10.1073/pnas.212410199. PMC 137894. PMID 12381789.
- French SW, Malone CS, Shen RR, Renard M, Henson SE, Miner MD et al. (2003). "Sp1 transactivation of the TCL1 oncogene". J. Biol. Chem. 278 (2): 948–55. doi:10.1074/jbc.M207166200. PMID 12421830.
- Herling M, Teitell MA, Shen RR, Medeiros LJ, Jones D (2004). "TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin". Blood 101 (12): 5007–9. doi:10.1182/blood-2002-10-3297. PMID 12576313.
- Kiss C, Nishikawa J, Takada K, Trivedi P, Klein G, Szekely L (2003). "T cell leukemia I oncogene expression depends on the presence of Epstein–Barr virus in the virus- carrying Burkitt lymphoma lines". Proc. Natl. Acad. Sci. U.S.A. 100 (8): 4813–8. doi:10.1073/pnas.0730710100. PMC 153638. PMID 12672960.
| |||||||||
